Nwasoluchukwu Okemdi Obidi

Mr. Nwasoluchukwu Okemdi Obidi

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2025
Verified
Journal Article
Closed access
NENzube Favour Ekpunobi
Nzube Favour Ekpunobi
Nwasoluchukwu Okemdi ObidiNwasoluchukwu Okemdi Obidi
Nwasoluchukwu Okemdi Obidi
OIOluwatosin Idowu
Oluwatosin Idowu
LOLydia Chidinma Okoye
Lydia Chidinma Okoye
CAChukwuebuka Kingsley Agu
Chukwuebuka Kingsley Agu
LULawrence Ifeanyi Uwanta
Lawrence Ifeanyi Uwanta
Breast cancer continues to be a major global health crisis, particularly impacting low-and middle-income nations like Nigeria. This research investigated breast cancer knowledge, attitudes, and preventative practices among students at Nnamdi Azikiwe University. A survey of 548 undergraduates and postgraduates revealed widespread awareness of the disease (99.3%), primarily attributed to social media (56.9%). Despite this high awareness, significant knowledge deficits persisted regarding risk factors, symptoms, and early detection techniques. Although most participants (90.5%) knew about breast self-examination (BSE), only two-thirds (67.2%) had performed it, and clinical breast examination (CBE) rates were alarmingly low (17.5%). Financial limitations (56.2%) and restricted access to healthcare facilities (44.5%) were identified as key obstacles to screening. These findings underscore the urgent need for focused educational programs, improved access to screening services, and robust public health campaigns to bridge the gap between knowledge and practice, ultimately promoting earlier detection and improved outcomes.

27 May 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
NENzube Favour Ekpunobi
Nzube Favour Ekpunobi
MUMalachy Ugwu
Malachy Ugwu
KAKingsley Agu
Kingsley Agu
CCChidimma Chukwunwejim
Chidimma Chukwunwejim
EOEddison Oghonyon
Eddison Oghonyon
Nwasoluchukwu Okemdi ObidiNwasoluchukwu Okemdi Obidi
Nwasoluchukwu Okemdi Obidi
Urinary tract infections (UTIs) remain a common and serious health challenge among pediatric populations, particularly in low- and middle-income countries. The emergence of extended-spectrum beta-lactamase (ESBL)-producing uropathogens significantly complicates treatment, increases the risk of complications, and burdens already fragile healthcare systems. This review provides a comprehensive analysis of the epidemiology, molecular mechanisms, clinical impact, and treatment challenges associated with ESBL-producing Enterobacteriaceae in pediatric UTIs, with a focused lens on Nigeria and the broader Sub-Saharan African region. We examine the predominance of Escherichia coli and Klebsiella pneumoniae as key ESBL producers, highlight the molecular dominance of CTX-M-15 and co-existing resistance determinants, and discuss the role of clonal expansion and horizontal gene transfer in the spread of resistance. Regional surveillance data reveal alarming ESBL prevalence rates of 40–75%, with multidrug resistance further narrowing treatment options. The implications are profound—ranging from delayed treatment and increased hospitalization to long-term renal complications in children. Despite the availability of phenotypic and molecular diagnostics, challenges persist due to limited access, infrastructural gaps, and under-resourced healthcare systems. This review underscores the urgent need for improved antimicrobial stewardship, investment in rapid diagnostics, and the establishment of pediatric-specific treatment guidelines. Addressing the burden of ESBL-producing uropathogens in Nigerian children is critical for safeguarding individual patient outcomes and mitigating the regional and global spread of antimicrobial resistance.

31 October 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
NENzube Favour Ekpunobi
Nzube Favour Ekpunobi
Nwasoluchukwu Okemdi ObidiNwasoluchukwu Okemdi Obidi
Nwasoluchukwu Okemdi Obidi
CCChiamaka Chidozie
Chiamaka Chidozie
KAKingsley Agu
Kingsley Agu
This study investigates the prevalence of pathogenic bacteria on eggshells from table eggs sold in Lagos markets, a major concern given eggs' role as a staple in the Nigerian diet. Fifty-one eggs were sampled from three poultry farms and three supermarkets, with bacterial isolation and identification conducted via microbiological assays and biochemical testing. The findings revealed that all eggshell samples (100%) were contaminated with various bacterial genera, including Staphylococcus aureus, Escherichia coli, Bacillus cereus, and Salmonella typhimurium. Staphylococcus aureus was the most frequently isolated organism, indicating a high potential risk for foodborne illness. Antimicrobial susceptibility tests indicated widespread resistance to first-line antibiotics, such as erythromycin and penicillin, with isolates only susceptible to gentamicin and ciprofloxacin. This study underscores the public health threat posed by contaminated eggs in Lagos and highlights the need for improved biosecurity measures, enhanced market hygiene, public awareness campaigns, and systematic surveillance under the One Health framework to combat bacterial contamination and antimicrobial resistance.

7 August 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
CRChukwunwejim C. R.
Chukwunwejim C. R.
NENzube Favour Ekpunobi
Nzube Favour Ekpunobi
EOEddison Igho Oghonyon
Eddison Igho Oghonyon
Nwasoluchukwu Okemdi ObidiNwasoluchukwu Okemdi Obidi
Nwasoluchukwu Okemdi Obidi
KAKingsley Agu
Kingsley Agu
The gut microbiome, a complex community of microorganisms residing in the gastrointestinal tract, is increasingly recognized as a critical player in cancer pathophysiology. Its influence extends beyond local gastrointestinal disorders to systemic diseases, including breast and colorectal cancers. This review examines current evidence on the interplay between gut microbial dysbiosis and the development, progression, and treatment response in both malignancies. In colorectal cancer (CRC), pathogenic bacteria such as Fusobacterium nucleatum, Escherichia coli, and Bacteroides fragilis have been implicated in tumor initiation and progression through mechanisms involving chronic inflammation, DNA damage, and immune modulation. Meanwhile, in breast cancer, the gut microbiome may contribute indirectly via regulation of estrogen metabolism, immune signaling, and systemic inflammation. Furthermore, the gut microbiota is increasingly being explored as a source of non-invasive biomarkers for early detection and disease monitoring, as well as a modifiable factor that could enhance therapeutic efficacy. Interventions such as probiotics, prebiotics, dietary modulation, and fecal microbiota transplantation (FMT) hold promise in reprogramming the microbiome to support antitumor responses and reduce treatment-related toxicity. Despite the growing body of research, translating these findings into clinical application requires deeper mechanistic understanding and standardized methodologies. This review emphasizes the need for longitudinal and multi-omics studies to unravel causal relationships and identify therapeutic targets. Understanding gut microbiome dynamics offers exciting opportunities for developing microbiota-informed strategies for cancer prevention, diagnosis, and therapy—particularly in breast and colorectal cancers.

4 September 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
SOSandra Chiamaka Okoye
Sandra Chiamaka Okoye
CCChidimma Chukwunwejim
Chidimma Chukwunwejim
NENzube Favour Ekpunobi
Nzube Favour Ekpunobi
OAOluwabunmi Ajasa
Oluwabunmi Ajasa
IOIsrael Ojuade
Israel Ojuade
KAKingsley Agu
Kingsley Agu
Escherichia coli (E. coli), a gram-negative bacterium, is a major concern for human and animal health. While most E. coli strains are commensal, some can become dangerous pathogens causing intestinal and systemic illnesses. Poultry meat is a potential source of infection; as resistant E. coli can be transmitted to humans through the food chain. This study aimed to determine the prevalence and antibiotic resistance patterns of E. coli O157:H7 in poultry feces from a live bird market in Lagos, Nigeria.Samples were enriched in TSB (9 mL) at 37 °C for 18–24 h, plated onto EMB and SMAC agar, and presumptive E. coli O157 isolates (non-sorbitol fermenters) were confirmed by latex agglutination, following the manufacturer’s instructions. Antimicrobial susceptibility testing was performed on confirmed E. coli O157 isolates using the Kirby-Bauer disc diffusion method.A total of 180 poultry fecal samples were analyzed. Out of these, 105 (58.33%) were identified as Escherichia coli isolates. The isolation process further revealed that 74 (41.11%) of the isolates were non-sorbitol fermenters, and 26 (14.44%) were confirmed as Escherichia coli O157:H7 using the latex agglutination test. The isolates showed high resistance to most of the tested antibiotics.The findings indicate a high prevalence and a high level of multidrug resistance in E. coli O157:H7 from indigenous chickens in Lagos' live bird markets. The presence of these pathogenic and resistant organisms poses a significant public health risk to individuals with direct contact with the birds and to consumers in Nigeria.

20 November 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
Nwasoluchukwu Okemdi ObidiNwasoluchukwu Okemdi Obidi
Nwasoluchukwu Okemdi Obidi
NENzube Favour Ekpunobi
Nzube Favour Ekpunobi
The increasing threat of antibiotic resistance in Africa, coupled with limited access to advanced antibiotics and high rates of bacterial infections, poses a serious public health challenge. Bacteriophages, viruses that target and destroy bacteria, present a promising alternative or complementary therapy to traditional antibiotics. Phage therapy leverages its unique ability to target specific bacterial strains without affecting the host's beneficial microbiota. It is an effective tool against multi-drug-resistant infections, particularly in resource-limited settings. This paper explores the potential of phage therapy in Africa, highlighting its advantages, such as specificity, minimal side effects, and cost-effectiveness, alongside its capability to tackle biofilm-associated and antibiotic-resistant infections. It reviews current research and collaborations, including case studies from Nigeria, Benin, and South Africa, that demonstrate the efficacy of phage therapy against pathogens like Staphylococcus aureus and Klebsiella pneumoniae. Furthermore, it discusses the challenges to implementation, such as regulatory hurdles, public scepticism, and infrastructure limitations, while emphasising the importance of developing local production and awareness campaigns. The paper concludes by recommending the integration of phage therapy into Africa’s healthcare strategies to address AMR. Through strategic partnerships, education, and regulatory frameworks, phage therapy could become a transformative solution, particularly for neglected diseases and infections common in low-resource settings. As Africa seeks innovative approaches to its growing AMR crisis, phage therapy stands out as a viable and adaptable option.